Christopher Peetz, Director, Chief Executive Officer, on June 01, 2026, sold 30,000 shares in Mirum Pharmaceuticals (MIRM) for $2,875,103. Following the Form 4 filing with the SEC, Peetz has control over a total of 381,809 common shares of the company, with 194,309 shares held directly and 187,500 controlled indirectly.
SEC Filing: